Abbott Laboratories News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

16.05.14	Nächste Pharmaübernahme: Abbott will CFR für 2,9 Milliarden Dollar kaufen (dpa-afx)
16.05.14	Neuer Milliarden-Deal: Abbott will CFR kaufen (AWP)
16.05.14	Abbott To Acquire CFR Pharma For Total Purchase Price Of $2.9 Bln Plus Debt (RTTNews)
16.05.14	Wall Street geht freundlich ins Wochenende -- US-Anleihen leichter -- Swisscom will Publigroupe übernehmen -- SMI schliesst im grünen Bereich -- Dax beendet Handel leicht tiefer (finanzen.ch)
12.05.14	Abbott Says Testing Platform May Identify Infections Faster Than Current Methods (RTTNews)
16.04.14	Abbott Laboratories Q1 Adj. Profit Beats View, Affirms 2014 Outlook (RTTNews)
16.04.14	Abbott Labs Q1 Profit Down, But Adj. EPS Tops View; Backs 2014 Profit Outlook (RTTNews)
16.04.14	Earnings Watch For April 16 (STJ, AXP, GOOG, IBM, SNDK) (RTTNews)
14.04.14	Abbott Gets FDA Clearance For ARCHITECT Clinical Chemistry Hemoglobin A1c Test (RTTNews)
10.04.14	Abbott Completes Enrollment Of Absorb Randomized Trials In U.S., Japan And China (RTTNews)
28.03.14	Abbott: FDA Okays Supera Stent For People With Peripheral Artery Disease (RTTNews)
28.02.14	Oasmia Pharma Receives FDA Conditional Approval For Paccal Vet-CA1 - Quick Facts (RTTNews)
15.02.14	Dan Loeb Buys Stakes In Blackberry, T-Mobile (RTTNews)
30.01.14	Moody's Affirms 19 Classes of BACM 2007-3 (Moodys)
22.01.14	ROUNDUP/Aktien New York Schluss: Überwiegend freundlich - IBM belastet Dow Jones (dpa-afx)
22.01.14	Abbott Laboratories -- Moody's: Abbott's upsized buyback program highlights more aggressive financial policies (Moodys)
22.01.14	Aktien New York: Dow im Minus - IBM enttäuscht Anleger (dpa-afx)
22.01.14	ROUNDUP/Aktien New York: Standardwerte im Minus - durchwachsene Quartalszahlen (dpa-afx)
22.01.14	Aktien New York: Standardwerte im Minus - durchwachsene Quartalszahlen (dpa-afx)
22.01.14	Abbott Laboratories Q4 Profit Meets View, Guides 2014 In Line (RTTNews)
22.01.14	Aktien New York Ausblick: Richtungslos erwartet - Unternehmenszahlen enttäuschen (dpa-afx)
22.01.14	Abbott Labs Q4 Profit Down, Adj. EPS Meets Estimates; Sees 2014 Earnings In Line (RTTNews)
22.01.14	Earnings Watch For January 22 (EBAY, NFLX, WDC, MSI, UTX, ABT, NSC) (RTTNews)
29.10.13	ROUNDUP: Biotech-Konzern Qiagen verdient mehr - Ausblick für 2013 bekräftigt (dpa-afx)
22.10.13	Absolute Software increases quarterly dividend by 20% (PR Newswire)
18.10.13	Pre-Market Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc. (PR Newswire)
18.10.13	New Study Demonstrates Importance of Oral Nutritional Supplements in Helping Hospitals Achieve Medicare Readmission Reduction Requirements (PR Newswire)
18.10.13	Clinical Study Results, Acquisitions, Upcoming Earnings Schedules, and New Drug Technologies- Research Report on Abbott, St. Jude Medical, Cigna, Edwards Lifesciences, and Novogen (PR Newswire)
16.10.13	Abbott Laboratories -- Moody's changes Abbott's rating outlook to negative from stable; affirms A1/P-1 ratings (Moodys)
16.10.13	Abbott Q3 Adj. Earnings Top Estimates, Boosts Dividend; Shares Up (RTTNews)
16.10.13	Abbott Q3 Profit Beats Estimates - Quick Facts (RTTNews)
16.10.13	Abbott Reports Third-Quarter 2013 Results (PR Newswire)
16.10.13	Abbott Reports Third-Quarter 2013 Results (PR Newswire)
16.10.13	Earnings Watch For October 16 (AXP, EBAY, BAC, PEP, STJ) (RTTNews)
15.10.13	Bellatrix Exploration Ltd. announces $175 million bought deal financing (PR Newswire)
15.10.13	Absolute Software Launches University Computing Initiative at Educause 2013 (PR Newswire)
15.10.13	Absolute Software Launches University Computing Initiative at Educause 2013 (PR Newswire)
11.10.13	New Study Shows Oral Nutritional Supplement Use in Pediatric Inpatients Is Associated with Decreases in Length of Hospital Stay, Costs (PR Newswire)
10.10.13	Upcoming Earnings Schedules, Acquisitions, Partnerships, and Unrestricted Grants for Community Programs - Research Report on Intuitive Surgical, Abbott, MAKO Surgical, Allscripts, and ABIOMED (PR Newswire)
07.10.13	Absolute Software Leads Endpoint Security and Management Discussion at Gartner Symposium ITxpo 2013 (PR Newswire)
04.10.13	Absolute Software Launches LoJack for Mobile Devices Theft Recovery Solution for Android Smartphones and Tablets in the United Kingdom (PR Newswire)
30.09.13	Conference Calls, New Appointments, Agreements, Pricing of Offerings and New Clinical Trials - Research Report on Abbott, Cubist, Pacific Biosciences, Synageva, and Oncothyreon (PR Newswire)
30.09.13	Advantage Provides Summary of Previously Announced Glacier Montney Resource Estimates (PR Newswire)
25.09.13	Abbott Hosts Conference Call for Third-Quarter Earnings (PR Newswire)
20.09.13	Early Briefing and Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc. (PR Newswire)
19.09.13	Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter (PR Newswire)
17.09.13	Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™ (PR Newswire)
17.09.13	Abbott Receives CE Mark for FreeStyle Optium Neo Blood Glucose and Ketone Monitoring System™ (PR Newswire)
17.09.13	Abbott Ranked Among Top 10 Best Companies by Working Mother Magazine (PR Newswire)
17.09.13	Successful Clinical Trials, Recognitions, Enrollment in Studies, Product Launches, and Strategic Announcements - Research Report on Boston Scientific, Gilead, Abbott, Actavis, and Covidien (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

12:26		STOXX-Handel: STOXX 50 verbucht mittags Zuschläge
12:26		Freundlicher Handel in London: FTSE 100 am Mittag in der Gewinnzone
12:26		Montagshandel in Frankfurt: DAX präsentiert sich mittags leichter
12:26		Starker Wochentag in Zürich: Das macht der SMI mittags
12:26		Zurückhaltung in Frankfurt: LUS-DAX notiert am Mittag im Minus
12:26		Zurückhaltung in Europa: Euro STOXX 50 am Montagmittag mit Abgaben
12:26		Starker Wochentag in Zürich: SPI verbucht Gewinne

12:26

STOXX-Handel: STOXX 50 verbucht mittags Zuschläge

12:26

Freundlicher Handel in London: FTSE 100 am Mittag in der Gewinnzone

12:26

Montagshandel in Frankfurt: DAX präsentiert sich mittags leichter

12:26

Starker Wochentag in Zürich: Das macht der SMI mittags

12:26

Zurückhaltung in Frankfurt: LUS-DAX notiert am Mittag im Minus

12:26

Zurückhaltung in Europa: Euro STOXX 50 am Montagmittag mit Abgaben

12:26

Starker Wochentag in Zürich: SPI verbucht Gewinne

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Swiss Re	130.40	1.48 %	K V
UBS Group	27.06	1.31 %	K V
CieFinRichemont	136.45	1.22 %	K V
Roche Hldg G	250.40	1.21 %	K V
Zurich Insur Gr	539.40	1.20 %	K V
Sonova Hldg	296.20	0.20 %	K V
Part Grp Hldg	1’213.00	0.17 %	K V
Nestle	74.04	0.08 %	K V
Sika	213.00	-0.09 %	K V
Geberit	510.00	-0.82 %	K V

Nachrichten zu Abbott Laboratories

Aktien Top/Flop

Abbott Laboratories Peer Group Nachrichten

Meistgelesene Nachrichten